Literature DB >> 34370287

The Role of NCOA4-Mediated Ferritinophagy in Ferroptosis.

Naiara Santana-Codina1, Ajami Gikandi1, Joseph D Mancias2.   

Abstract

Nuclear receptor coactivator 4 (NCOA4) is a selective cargo receptor that mediates the autophagic degradation of ferritin, the cytosolic iron storage complex, in a process known as ferritinophagy. NCOA4-mediated ferritinophagy is required to maintain intracellular and systemic iron homeostasis and thereby iron-dependent physiologic processes such as erythropoiesis. Given this role of ferritinophagy in regulating iron homeostasis, modulating NCOA4-mediated ferritinophagic flux alters sensitivity to ferroptosis, a non-apoptotic iron-dependent form of cell death triggered by peroxidation of polyunsaturated fatty acids (PUFAs). A role for ferroptosis has been established in the pathophysiology of cancer and neurodegeneration; however, the importance of ferritinophagy in these pathologies remains largely unknown. Here, we review the available evidence on biochemical regulation of NCOA4-mediated ferritinophagy and its role in modulating sensitivity to innate and induced ferroptosis in neurodegenerative diseases and cancer. Finally, we evaluate the potential of modulating ferritinophagy in combination with ferroptosis inducers as a therapeutic strategy.
© 2021. Springer Nature Switzerland AG.

Entities:  

Keywords:  Autophagy; Cancer; Ferritin; Ferritinophagy; NCOA4; Neurodegeneration

Mesh:

Substances:

Year:  2021        PMID: 34370287     DOI: 10.1007/978-3-030-62026-4_4

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  132 in total

1.  Interaction of the putative androgen receptor-specific coactivator ARA70/ELE1alpha with multiple steroid receptors and identification of an internally deleted ELE1beta isoform.

Authors:  P Alen; F Claessens; E Schoenmakers; J V Swinnen; G Verhoeven; W Rombauts; B Peeters
Journal:  Mol Endocrinol       Date:  1999-01

2.  Distinct mechanisms of ferritin delivery to lysosomes in iron-depleted and iron-replete cells.

Authors:  Takeshi Asano; Masaaki Komatsu; Yuko Yamaguchi-Iwai; Fuyuki Ishikawa; Noboru Mizushima; Kazuhiro Iwai
Journal:  Mol Cell Biol       Date:  2011-03-28       Impact factor: 4.272

3.  Cysteine depletion induces pancreatic tumor ferroptosis in mice.

Authors:  Michael A Badgley; Daniel M Kremer; H Carlo Maurer; Kathleen E DelGiorno; Ho-Joon Lee; Vinee Purohit; Irina R Sagalovskiy; Alice Ma; Jonathan Kapilian; Christina E M Firl; Amanda R Decker; Steve A Sastra; Carmine F Palermo; Leonardo R Andrade; Peter Sajjakulnukit; Li Zhang; Zachary P Tolstyka; Tal Hirschhorn; Candice Lamb; Tong Liu; Wei Gu; E Scott Seeley; Everett Stone; George Georgiou; Uri Manor; Alina Iuga; Geoffrey M Wahl; Brent R Stockwell; Costas A Lyssiotis; Kenneth P Olive
Journal:  Science       Date:  2020-04-03       Impact factor: 47.728

Review 4.  The Alzheimer's Disease Clinical Spectrum: Diagnosis and Management.

Authors:  Alireza Atri
Journal:  Med Clin North Am       Date:  2019-03       Impact factor: 5.456

Review 5.  Huntington disease.

Authors:  Gillian P Bates; Ray Dorsey; James F Gusella; Michael R Hayden; Chris Kay; Blair R Leavitt; Martha Nance; Christopher A Ross; Rachael I Scahill; Ronald Wetzel; Edward J Wild; Sarah J Tabrizi
Journal:  Nat Rev Dis Primers       Date:  2015-04-23       Impact factor: 52.329

6.  NCOA4 transcriptional coactivator inhibits activation of DNA replication origins.

Authors:  Roberto Bellelli; Maria Domenica Castellone; Teresa Guida; Roberto Limongello; Nina Alayne Dathan; Francesco Merolla; Anna Maria Cirafici; Andrea Affuso; Hisao Masai; Vincenzo Costanzo; Domenico Grieco; Alfredo Fusco; Massimo Santoro; Francesca Carlomagno
Journal:  Mol Cell       Date:  2014-06-05       Impact factor: 17.970

7.  Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE.

Authors:  Scott Ayton; Noel G Faux; Ashley I Bush
Journal:  Nat Commun       Date:  2015-05-19       Impact factor: 14.919

8.  Iron addiction: a novel therapeutic target in ovarian cancer.

Authors:  D Basuli; L Tesfay; Z Deng; B Paul; Y Yamamoto; G Ning; W Xian; F McKeon; M Lynch; C P Crum; P Hegde; M Brewer; X Wang; L D Miller; N Dyment; F M Torti; S V Torti
Journal:  Oncogene       Date:  2017-03-20       Impact factor: 9.867

9.  NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis.

Authors:  Samantha W Alvarez; Vladislav O Sviderskiy; Erdem M Terzi; Thales Papagiannakopoulos; Andre L Moreira; Sylvia Adams; David M Sabatini; Kıvanç Birsoy; Richard Possemato
Journal:  Nature       Date:  2017-11-22       Impact factor: 69.504

Review 10.  Targeting Nrf2 to Suppress Ferroptosis and Mitochondrial Dysfunction in Neurodegeneration.

Authors:  Moataz Abdalkader; Riikka Lampinen; Katja M Kanninen; Tarja M Malm; Jeffrey R Liddell
Journal:  Front Neurosci       Date:  2018-07-10       Impact factor: 4.677

View more
  14 in total

Review 1.  Ferroptosis: A Novel Therapeutic Direction of Spinal Cord Injury.

Authors:  Qianlong Zhao; Feifei Liu; Bangyu Zhou; Hongzhi Liu; Xiaowei Wang; Shaobo Li
Journal:  Comput Math Methods Med       Date:  2022-07-12       Impact factor: 2.809

2.  Tetrandrine Citrate Suppresses Breast Cancer via Depletion of Glutathione Peroxidase 4 and Activation of Nuclear Receptor Coactivator 4-Mediated Ferritinophagy.

Authors:  Jiameng Yin; Yajun Lin; Weiwei Fang; Xin Zhang; Jie Wei; Gang Hu; Pu Liu; Jie Niu; Jun Guo; Yongzhan Zhen; Jian Li
Journal:  Front Pharmacol       Date:  2022-05-09       Impact factor: 5.988

Review 3.  Targeting ferroptosis in acute kidney injury.

Authors:  Lihua Ni; Cheng Yuan; Xiaoyan Wu
Journal:  Cell Death Dis       Date:  2022-02-24       Impact factor: 9.685

4.  NCOA4-Mediated Ferroptosis in Bronchial Epithelial Cells Promotes Macrophage M2 Polarization in COPD Emphysema.

Authors:  Jiaxin Liu; Zixiao Zhang; Yue Yang; Tingting Di; Yan Wu; Tao Bian
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-03-30

5.  Exosomes and ferroptosis: roles in tumour regulation and new cancer therapies.

Authors:  Yixin Shi; Bingrun Qiu; Linyang Huang; Jie Lin; Yiling Li; Yiting Ze; Chenglong Huang; Yang Yao
Journal:  PeerJ       Date:  2022-04-26       Impact factor: 3.061

Review 6.  Ferroptosis as a Novel Therapeutic Target for Diabetes and Its Complications.

Authors:  Xi-Ding Yang; Yong-Yu Yang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-29       Impact factor: 5.555

Review 7.  The Role of Ferritin in Health and Disease: Recent Advances and Understandings.

Authors:  Nikhil Kumar Kotla; Priyata Dutta; Sanjana Parimi; Nupur K Das
Journal:  Metabolites       Date:  2022-06-30

Review 8.  Ferroptosis, necroptosis, and pyroptosis in the occurrence and development of ovarian cancer.

Authors:  Chunmei Zhang; Ning Liu
Journal:  Front Immunol       Date:  2022-07-25       Impact factor: 8.786

9.  Levistilide a Induces Ferroptosis by Activating the Nrf2/HO-1 Signaling Pathway in Breast Cancer Cells.

Authors:  Shangwen Jing; Yantong Lu; Jing Zhang; Yan Ren; Yousheng Mo; Dongdong Liu; Lining Duan; Zhongyu Yuan; Changjun Wang; Qi Wang
Journal:  Drug Des Devel Ther       Date:  2022-09-07       Impact factor: 4.319

Review 10.  Autophagy-Associated Immunogenic Modulation and Its Applications in Cancer Therapy.

Authors:  Zhuxi Duan; Yu Shi; Qun Lin; Ahmed Hamaï; Maryam Mehrpour; Chang Gong
Journal:  Cells       Date:  2022-07-28       Impact factor: 7.666

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.